Recall Register

Drug recall: Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-count blister…

Class III FDA enforcement event 93336. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots

Class III, in the words of FDA

a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences

NCS Healthcare of Kentucky Inc started this drug recall on 27 Oct 2023. The firm address in the FDA record is in Glasgow, KY. FDA put the recall in Class III. FDA event 93336 has 2 product records. The first FDA enforcement report date is 29 Nov 2023. The record gives the status Terminated, with the termination date 14 Jul 2024.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide USA

Recalling firm

NCS Healthcare of Kentucky Inc, Glasgow, KY.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

2 product records in the event.

FDA event 93336: product records
Recall numberProductQuantityClassStatusReport date
D-0113-2024Buspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-count blister card (NDC 0615-7718-39), Rx only, Mfd By Pliva HRVATSKA for Teva USA, PKG by Vangard Glasgow, KY 42141.1,344 cardsClass IIITerminated29 Nov 2023
D-0114-2024Lisinopril Tablets USP 20 mg, packaged in a) 15-count blister card (NDC 0615-7718-05), b) 30-count blister card (NDC 0615-8255-39), Rx only, Mfd By Lupin, PKG by Vangard Glasgow, KY 42141.12 cardsClass IIITerminated29 Nov 2023

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class III: The lowest of the three FDA recall classes.

The event in context

Drug events that started in 2023
281
Share of these events in Class III
26%
Product records in this event
2Median of the firm: 2
Events of the firm on the register
2

Other events of the firm

Other FDA enforcement events of NCS Healthcare of Kentucky Inc
InitiatedProduct (first record)TypeClassRecords
28 Jan 2020Glycopyrrolate Tabs, USP, 1 mg, 30-count unit dose blister card, FOR INSTITUTIONAL USE ONLY, Rx Only, Packaged by Vangar Event 84992DrugClass II1

Official channels

Cite this page

Recall Register. FDA enforcement event 93336. https://recallregister.com/fda/iii/93336/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide USA
What quantity of product is in FDA event 93336?
The event has 2 product records. The first record gives this quantity: 1,344 cards
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2023 have the same class?
26% of the 281 drug events that started in 2023 are in Class III.